It's a new week, which means it's time to check the most interesting insider purchases.

After reading through numerous filings using insider tracking tool Form 4 Oracle, I've uncovered my top five this week.

The week's buying


Closing Price 9/6/07

Total Value Purchased

52-Week Change

Eddie Bauer (NASDAQ:EBHI)




Meritage Homes (NYSE:MTH)








Poniard Pharmaceuticals (NASDAQ:PARD)




Tenet Healthcare (NYSE:THC)




Sources:, Yahoo! Finance, Form 4 Oracle, SEC filings.

Caught in the bubble babble
Once more, we dig into a stock hurt by the credit crunch that's battered the stock market in general and real estate stocks in particular. Is Meritage Homes, which hawks family-sized dwellings through the South and West, worth the risk?

Not many in our Motley Fool CAPS investor-intelligence database think so.


Meritage Homes

CAPS stars (5 max)


Total ratings


Bullish ratings


Bull ratio


Bearish ratings


Bear ratio


Bullish pitches


Bearish pitches


Data current as of Sept. 6, 2007.

After looking at the numbers, I understand why. Meritage builds homes in six states. Four of them -- Arizona, California, Florida, and Nevada -- host one-third of the nation's subprime adjustable-rate mortgages. But now these death-spiral loans are out of style, which means no more borrowing a cool million to get that hot, un-air-conditioned garage in SoCal.

The timing couldn't be worse for Meritage, which had to write off $100 million in inventory in July. Returns on equity and capital have collapsed into the single digits. Free cash flow is down to negative $152 million over the trailing 12 months. Can this relatively small company, once known only as a local Phoenix-area builder, survive the gnashing of teeth that's still to come?

At least two investors think so. Board member Robert Sarver, who also runs Western Alliance Bancorp (NYSE:WAL), bought 15,100 shares a week ago today. CEO Steven Hilton joined him the same day, in buying 3,150 shares at $16.49 a pop.

They may prove to be prescient. Even though Meritage's debt load is huge, it accounts for just 48% of total capital, according to Capital IQ. By contrast, peers Centex (NYSE:CTX) and KB Home count debt as more than 50% of capital.

What's more, by today's prices, each dollar of Meritage revenue is worth just $0.16. That's well below the industry average of $0.30 and the average of it peers. Accordingly, I expect any modest sales improvements to have a substantial impact on the stock. Look for Meritage to be added to my CAPS watch list later today.

Oh, my, OYO
Then there's a stock I wish I'd put on my watch list years ago: OYO Geospace, which fellow Fool Bill Mann picked for Motley Fool Hidden Gems in April of last year. The shares are up almost 63% since then. (Hey, Bill. Call me next time, OK?)

But OYO, which specializes in monitoring oil and gas reserves, could still be cheap. That's according to chief technical officer Michael Sheen, who, shortly after exercising and then selling a little more than 10,000 shares acquired via options, bought 10,000 more shares on the open market.

Good move. Returns on capital have rocketed in recent quarters, yet mutual funds continue to ignore the stock. (They own less than 50% of the outstanding shares.) I don't think that will last. Thus, I'm adding OYO Geospace to my CAPS watch list today.

And that's your update. See you back here next week, when we dig through more insider deals in search of the next home run stock.

Get the inside scoop on stocks of all sizes with related Foolishness:

Get all of the inside information you need in our collection of investing newsletters. From wallflowerish small caps to swashbuckling Rule Breakers, we've got something for every investor. Get in on the action today; all of our newsletters offer a 30-day risk-free trial. All you have to lose is the prospect of better returns.

Fool contributor Tim Beyers, who is ranked 7,845 out of more than 60,000 participants in CAPS, didn't own stock in any of the companies mentioned in this article at the time of publication. Find Tim's portfolio here and his latest blog commentary here. The Motley Fool has a disclosure policy.